| Product Code: ETC7649680 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Depression Drugs Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Depression Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Depression Drugs Market - Industry Life Cycle |
3.4 Israel Depression Drugs Market - Porter's Five Forces |
3.5 Israel Depression Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Israel Depression Drugs Market Revenues & Volume Share, By Disease, 2021 & 2031F |
4 Israel Depression Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about mental health and depression |
4.2.2 Rise in the number of diagnosed cases of depression in Israel |
4.2.3 Growing acceptance and use of pharmaceutical interventions for treating depression |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 High cost associated with research and development of depression drugs |
4.3.3 Stigma associated with mental health issues leading to underreporting and underdiagnosis of depression |
5 Israel Depression Drugs Market Trends |
6 Israel Depression Drugs Market, By Types |
6.1 Israel Depression Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Israel Depression Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Israel Depression Drugs Market Revenues & Volume, By Selective Serotonin Reuptake Inhibitors (SSRs), 2021- 2031F |
6.1.4 Israel Depression Drugs Market Revenues & Volume, By Norepinephrine Reuptake Inhibitors (SNRIs), 2021- 2031F |
6.1.5 Israel Depression Drugs Market Revenues & Volume, By Atypical Antidepressants, 2021- 2031F |
6.1.6 Israel Depression Drugs Market Revenues & Volume, By Tricyclic Antidepressants, 2021- 2031F |
6.1.7 Israel Depression Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Depression Drugs Market, By Disease |
6.2.1 Overview and Analysis |
6.2.2 Israel Depression Drugs Market Revenues & Volume, By Schizophrenia, 2021- 2031F |
6.2.3 Israel Depression Drugs Market Revenues & Volume, By Bipolar I Disorder, 2021- 2031F |
6.2.4 Israel Depression Drugs Market Revenues & Volume, By Obsessive-Compulsive disorders (OCD), 2021- 2031F |
6.2.5 Israel Depression Drugs Market Revenues & Volume, By Anxiety Disorder, 2021- 2031F |
6.2.6 Israel Depression Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Depression Drugs Market Import-Export Trade Statistics |
7.1 Israel Depression Drugs Market Export to Major Countries |
7.2 Israel Depression Drugs Market Imports from Major Countries |
8 Israel Depression Drugs Market Key Performance Indicators |
8.1 Number of mental health awareness campaigns conducted annually |
8.2 Percentage increase in diagnosed cases of depression in Israel |
8.3 Number of new depression drugs approved by regulatory authorities each year |
9 Israel Depression Drugs Market - Opportunity Assessment |
9.1 Israel Depression Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Israel Depression Drugs Market Opportunity Assessment, By Disease, 2021 & 2031F |
10 Israel Depression Drugs Market - Competitive Landscape |
10.1 Israel Depression Drugs Market Revenue Share, By Companies, 2024 |
10.2 Israel Depression Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here